The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chimeric antigen receptor (CAR+) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC).
Susan F. Slovin
No relevant relationships to disclose
Xiuyan Wang
No relevant relationships to disclose
Melanie Hullings
No relevant relationships to disclose
Gabrielle Arauz
No relevant relationships to disclose
Shirley Bartido
No relevant relationships to disclose
Jason Stuart Lewis
No relevant relationships to disclose
Heiko Schöder
No relevant relationships to disclose
Pat Zanzonico
No relevant relationships to disclose
Howard I. Scher
No relevant relationships to disclose
Michel Sadelain
No relevant relationships to disclose
Isabelle Riviere
No relevant relationships to disclose